30 closest matches · ranked by relevance
Post-cholecystectomy Gastrointestinal Spasms
Primary: Percentage of "Responders" to Duspatalin® Therapy — 63.6; 36.4 percentage of participants
Postcholecystectomy Syndrome
Primary: the Number of the Participants Have Postoperative RUQ Pain — 3; 9 number of participants
Bile Acid Malabsorption · Cholelithiasis
Primary: Change in Stimulated Fibroblast Growth Factor 19 (FGF19) From Baseline Before Versus Post Cholecystectomy — 81; 186 pg per mL — p=0.03
Pain Management
Primary: Postoperative Pain Examination — 3; 5; 2; 3 score on a scale
Postoperative Pain
Primary: Pain Measured on Verbal Scale of 0-10 — 2.7; 1.7; 3; 2.1 units on a scale
Acute Cholecystitis · Empyema of Gallbladder · Abscess of Gallbladder
Primary: Complication — 7; 7 participants
Acute Cholecystitis
Primary: Number of Participants With Infectious Postoperative Complications — 8; 7 Participants
Postural Tachycardia Syndrome
Primary: C-peptide Levels After Oral Glucose Tolerance Test — 40.6; 23.2 pg/mL
Constipation
Primary: Patient Assessment of Constipation Symptoms Questionnaire (PAC-SYM) Score — 1.1; 0.6 score
Cholelithiasis
Primary: Number of Participants With Subhepatic Collection at Ultrasonographic Examination — 45; 46 Participants
Irritable Bowel Syndrome
Primary: Number of Participants With Post Infectious Irritable Bowel Syndrome — 23; 114 participants
Esophageal Spasm
Primary: Esophageal Symptoms Questionnaire Score (ESQ) — 24; 35 score on a scale
Pancreaticobiliary Reflux
Primary: Amylase and Lipase Values in Gallbladder Bile — 5.5; 181.2; 9.5; 434.8 mg/dl
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer
Primary: Postoperative Length of Hospital Stay — 4.4; 4.3 days — p=0.34
Acute Pancreatitis · Intra-abdominal Hypertension
Primary: Percent Change of IAP After Treatment — -18.7; -5.4; -27.2; -20.0 percent change of IAP
Bowel Dysfunction
Primary: Time to the Resumption of Bowel Functioning as Assessed by Flatus Passage — 24.1; 39.1 hours — p=<0.05
Pain, Postoperative · Chronic Postoperative Pain
Primary: VAS Score Changes ( Cough) During 24 h Postoperatively — 32; 31 mm
Post Operative Ileus
Primary: Post-Operative Hospital Stay — 79.93; 72.94 hours — p=0.665
Healthy
Primary: Coefficient of Variation (CV) for Gallbladder Ejection Fraction (GBEF) for Each Infusion Method — 51.66; 62.75; 71.38; 40.46 percentage
Gall Stone Disease · Polyp
Primary: Duration of Operation — 36.56; 30.75 minutes
ERCP · Pancreatic Diseases · Bile Duct Diseases
Primary: The Grades of the Number of Duodenal Contractions — 1.13; 1.17 scores on a scale
Gastrointestinal Diseases · Ileus Paralytic · Ileus
Primary: GI Functional Recovery — 47.94 hours
Functional Disorder of Intestine
Primary: Time to First Post-op Bowel Movement — 64; 77 hours
Postoperative Gastrointestinal Dysfunction
Primary: Time From End of the Surgery to Resolution of Upper and Lower Gastrointestinal (GI) Function Postsurgery as Assessed by the Investigator — 1.89; 2.76; 2.59; 2.62 days…
Pain, Postoperative
Primary: Reduction in Postoperative Pain — 9.2; 10; 3.3; 9.3 units on a scale
Pancreatobiliary Disease · Altered Gastric Anatomy
Primary: Papilla or Duct-enterostomy Was Reached — 10 ERCPs
Irritable Bowel Syndrome · Constipation
Primary: Change in Gastric Emptying Time, Small Bowel Transit Time, Colon Transit Time and Whole Gut Transit Time From Baseline — 5.49; 6.52; -0.16; 0.2 hours
Cholecystitis
Primary: Complications Related to ICG — 0; 0 % of Participants with Complications
Intestinal Diseases
Primary: PID From Pre-dose Baseline at 20 Minutes After First Injection. — -4.09; -3.66 Units on a scale — p=<0.0001
Irritable Bowel Syndrome · Small Intestinal Bacterial Overgrowth
Primary: Global Improvement Scale — 4.3; 4.3 units on a scale — p=0.26